Trevor L. Wahlbrink | Ampersand Capital

Trevor L. Wahlbrink

Trevor L. Wahlbrink



Trevor joined Ampersand in 2012. Most recently he was an Associate at Morgan Keegan where he worked on a number of leveraged acquisitions and recapitalizations of middle market companies. Prior to Morgan Keegan, Trevor was at Covington Associates, a specialty investment bank, where he focused on healthcare M&A transactions. Trevor currently serves as Chairman of the Board of Vantage MedTech. Trevor’s current and past board seats include Avista Pharma Solutions, Confluent, MedPharm, Elite One, ETE Medical, Iuvo BioSciences, N2 Biomedical, Phosphorex, Precision Coating, and TriPharm. Trevor holds a M.S. and B.S. in Accounting and Finance from Boston College and is a CFA charterholder.